Zenas BioPharma, Inc. Common Stock (ZBIO) earnings · rev $10.0M
These earnings events as JSON? API free 100/dayZenas BioPharma, Inc. Common Stock (ZBIO) is a biotechnology company listed on US.
This ZBIO earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ZBIO revenue for 2025-12-31 was $10.0M. Net income was -$377.7M. Revenue was up 100.0% from 2024-12-31 to 2025-12-31. ZBIO currently screens at market cap $798.0M.
When the next ZBIO 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 100.0% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full ZBIO research stays on the stock page; the tape stays on the quote page.
ZBIO earnings FAQ
What are ZBIO's latest revenue and net income?
Latest cached Zenas BioPharma, Inc. Common Stock (ZBIO) revenue for Dec 31, 2025 was $10.0M. Net income was -$377.7M. Statements: https://lician.com/financials/zbio
What is ZBIO's latest diluted EPS?
Latest cached Zenas BioPharma, Inc. Common Stock (ZBIO) diluted EPS for Dec 31, 2025 was -$8.44.
What period does the latest ZBIO earnings print cover?
The latest cached Zenas BioPharma, Inc. Common Stock (ZBIO) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did ZBIO revenue change from the prior cached period?
Cached Zenas BioPharma, Inc. Common Stock (ZBIO) revenue was up 100.0% from $5.0M (Dec 31, 2024) to $10.0M (Dec 31, 2025). Statements: https://lician.com/financials/zbio
Where are ZBIO earnings listed?
Cached earnings facts for Zenas BioPharma, Inc. Common Stock (ZBIO) are listed at https://lician.com/earnings/zbio. Statements: https://lician.com/financials/zbio
Not investment advice.